Micrel Inc (MCRL) 13.86 $MCRL Infusion Pumps Ma
Post# of 273258
Posted On: 09/02/2016 3:19:24 PM
Micrel Inc (MCRL) 13.86 $MCRL
Infusion Pumps Market 2015-2025 - 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide
M2 - Thu Dec 03, 7:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/h9gtdp/infusion_pumps) has announced the addition of the "Infusion Pumps Market, 2015-2025" report to their offering. The Infusion Pumps Market, 2015-2025 report provides a comprehensive study of the current state of infusion pumps market and the likely future evolution of these devices over the next decade. The study covers various types of infusion pumps that are used across several application areas. The current generation of these devices, being reliable and easy to use, have found wide acceptance in both homecare and hospital market. Infusion pumps are a class of drug delivery devices that have found wide adoption across different application areas. Their popularity can be attributed to their reliable, user friendly features and ergonomic design. The market has a wide array of different types of infusion pumps (volumetric, syringe, implantable, elastomeric, ambulatory and others); combined, they offer a large range of infusion volume, flow rate, occlusion alarm pressure range and many other technical parameters that can be adjusted according to the patient's requirements and care areas.These pumps have strengthened their position in a variety of application areas including oncology, diabetes, pain management, enteral feeding and general infusion. Several established firms as well as emerging players are currently competing in this market. Companies have regularly come up with technological advancements aimed at increasing the reliability and safety of these pumps. Examples of technological / design innovations include introduction of intuitive coloured touch screen, drug libraries, user friendly interface, compact design, improved accuracy, automated power saving mode and air-in-line detection.The introduction of smart infusion pumps has been an important step in the growth of this market. Despite the fact that the current market is significantly mature, a number of technological advancements from established and new players have sustained the growth momentum.Companies are continuously on the lookout for new avenues of growth in terms of novel features; this is expected to result in an even wider adoption going forward. Report Highlights: - During the course of our study, we identified over 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide. - The fragmented market is well distributed across different regions. Established companies such as (in alphabetical order) Baxter, B. Braun, Cane Medical Technology, Daiwha, Fresenius Kabi, GF Foures, Hospira, Medtronic, Micrel Medical Devices, Mindray, Smiths Medical, which have a wide portfolio of infusion pump devices are staring at growing competition from several mid-sized players and upcoming start-ups. - Examples of start-ups / smaller firms (in alphabetical order) include CareFusion, Cellnovo, CME Medical, Expanding Industry Limited, Flowonix, Summit Medical Products, Zyno Medical (complete list in Chapter 4). As has been observed in the case of other medical devices, the newer / smaller players will continue to foster more innovation and drive the market further. - The increasing number of partnerships among several players clearly indicates the growth and changes being witnessed in the market. These collaborations range from product / software development, distribution arrangements and acquisitions. - We expect the overall market to grow at an annualised growth rate of 3.8% during the period 2015-2025. Specific pockets of growth will come from wider adoption for oncology, diabetes and pain management applications. In terms of product types, ambulatory infusion pumps are likely to witness a relatively higher growth. - Advancements in device safety, software developments, accuracy rates and incorporation of additional user friendly features are likely to act as key enablers for future growth. The homecare market, specifically, is expected to grow its share in the future owing to the fact that it is cost effective and reduces the hospital expenses incurred by patients for various treatments. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Infusion Pumps For General Infusion 6. Infusion Pumps For Pain Management 7. Infusion Pumps For Oncology 8. Infusion Pumps For Insulin Administration 9. Case Studies 10. Market Forecast 11. Company Profiles 12. Conclusion 13. Appendix 1: Tabulated Data 14. Appendix 2: List Of Companies And Oragnisations Companies Mentioned - 3AF Group - AAMI Foundation - Abbott - Advanced Infusion - AKAS Medical - ALCOR Scientific - American Association of Critical-Care Nurses (AACN) - American Society of Regional Anaesthesia and Acute Pain Medicine (ASRA) - Amerinet - Angel Electronics - AngioDynamics - Animas - Arcomed - ASCOR - Asklepios Hospital Group - Atom Medical - B. Braun - Baxter - Becton Dickinson - Beijing KellyMed - Bigfoot Biomedical - Blue Box Medical - Cane Medical - CareFusion - Cellnovo - Centers for Disease Control and Prevention - Cerner - Changsha Jianyuan - CME Medical - CODAN ARGUS - Codman (J&J) - Committee for Medical Products for Human Use - CONNECT - Contec Medical - Covidien For more information visit http://www.researchandmarkets.com/research/h9...sion_pumps
MDT: 87.34 (+0.36), CFN: 59.91 (-0.06), MCRL: 13.86 (-0.09), CERN: 64.70 (-0.31)
Microchip Technology Announces Record Revenue For Second Quarter Fiscal Year 2016 And 100th Consecutive Quarter Of Profitability
PR Newswire - Wed Nov 04, 3:15PM CST
(NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today reported results for the three months ended September 30, 2015 as summarized in the following table:
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019
M2 - Wed Oct 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q92d5h/global_infusion) has announced the addition of the "Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019" report to their offering. Chronic pain is a worldwide burden that is estimated to have a burden of over 600 billion dollars in United States alone, whereas cancer and diabetes have an annual burden of US$ 243.0 billion and US$ 188.0 billion. This report provides an in-depth perspective on the revenue generated through demand from end-users such as Hospitals, HomeCare, Clinics and Infusion Centers or Infusion Pharmacies. It also provides another perspective of demand of infusion pumps market by applications such as Pain Management, Chemotherapy or Oncology, Infection Management (infusion of antimicrobial agents), Nutrition Management (Enteral and TPN), Insulin or Diabetes Management and Pediatric Infusion. Diabetes, cancer and chronic pain are long term illnesses that are increasing in incidence each year. In recent years the incidence and prevalence of diabetes has reached exponential levels with a global prevalence pegged by the WHO to be 9% worldwide among adults only. There is also a growing number of adolescent diabetes occurring worldwide. The rising population of diabetes coupled by increasing adoption of insulin pumps by Type II diabetics will propel the market for these devices in coming years. Increasing number of trauma patients are opting for implantable infusion pumps or IBT therapies. The combined rise of diabetes, cancer and chronic pain will push the market for infusion pumps significantly through the forecast period and even beyond it. With the advent of infusion pumps the medical community expected to reduce the number of errors, however even with all the medication administration errors, the single greatest source was human error. The most prominent disadvantage till recent times was that infusion pumps could not read the age, weight and other parameters of the patient from medical records in order to create filters and barriers for medication administration. The infusion pumps have to be programmed for use each time which have been causing massive errors where people have tragically died due to overdose of drugs. Close to 3 million people are estimated to rely on home infusions each year in United States alone and the trend is expected to be the same in Europe as well. Increasing demand for healthcare services and products to be reached in patient comfort zones will continue in coming years driving the growth of the market. The Medicare Home Infusion Site of Care Act of 2015 provides a pathway for reimbursement for the professional services, supplies and equipment associated with infusion therapy in the home under Medicare Part B. Commercial and research activities of over 40 players in the infusion devices market were analysed within this report. Infusion has been used in medicine since eons but has advanced very quickly in the last 20-30 odd years. There have been many strategies followed by companies to market their products and increase overall presence in various segments. Due to the integral working of pharmaceutical products and electronic devices together, the infusion pumps market lies at the overlap of the healthcare market which is broadly categorized into medical devices and pharmaceuticals. It is one of the largest drug delivery technologies today. The Global Infusion Pumps Market is highly fragmented. Key Topics Covered: Chapter 1 Preface Chapter 2 Pr?cis Chapter 3 Market Dynamics Chapter 4 Infusion Pumps & Accessories - Global Market Size Assessment, by Products, Forecast: 2015 - 2019 Chapter 5 Infusion Pumps - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019 Chapter 6 Infusion Pumps - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019 Chapter 7 Infusion Pumps & Accessories - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019 Chapter 8 Key Players Analysis: Infusion Pumps Market, 2014 (%) - 3AF Group - Akas Medical - Arcomed AG - Ascor SA - B Braun - Baxter - Caesarea Medical Electronics - CareFusion - CME Medical - Codan Argus - Codman & Shurtleff) - Diaken Medical Co Ltd - Flowonix - Fresnius Kabi - Halyard Medical - Hospira (Pfizer) - Insulet Corporation - Johnson & Johnson (Animas - KD Scientific - Medtronic Inc - Micrel Medical Devices - Mindray Medical - Moog Medical - Pancreum - Plenumtech - Roche - Schiller AG - Smiths Medical - Tandem - Tricumed - TSS Medical - Unilife - Zyno Medical For more information visit http://www.researchandmarkets.com/research/q9...l_infusion
JNJ: 119.22 (+0.14), PODD: 42.96 (+0.50), MDT: 87.34 (+0.36), MOG.A: 60.06 (+0.90), CFN: 59.91 (-0.06), MCRL: 13.86 (-0.09)
Microchip Technology Raises Guidance For Net Sales And EPS For Second Quarter Of Fiscal 2016
PR Newswire - Tue Sep 08, 6:00AM CDT
Microchip Technology Incorporated (NASDAQ: MCHP), a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today narrowed the range and increased the mid-point of its prior guidance for net sales and earnings per share for its fiscal second quarter of fiscal 2016 ending September 30, 2015. Microchip's core business is tracking towards our original guidance while Micrel sales for the partial quarter are ahead of our original guidance. Microchip previously provided guidance on August 3, 2015 for consolidated non-GAAP net sales to be between $532 million and $569 million with a mid- point of $550.5 million. Microchip now expects consolidated non-GAAP net sales to be between $545 million and $563 million with a mid-point of $554 million. Microchip now expects non-GAAP earnings per share to be between 60 and 66 cents per share. The original guidance for non-GAAP earning per share was between 58 and 66 cents per share.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
The Global MEMS Device, Equipment and Materials Markets: Forecasts and Strategies for Vendors and Foundries
M2 - Tue Sep 01, 11:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz9z2n/the_global_mems) has announced the addition of the "The Global MEMS Device, Equipment, and Materials Markets: Forecasts and Strategies for Vendors and Foundries" report to their offering. This vision of MEMS whereby microsensors, microactuators and microelectronics and other technologies, can be integrated onto a single microchip is expected to be one of the most important technological breakthroughs of the future. A significant portion of MEMS manufacturing technology has come from the IC industry. MEMS devices can be made using silicon wafers and the manufacturing process can incorporates semiconductor manufacturing processes such as sputtering, deposition, etching and lithography. This report analyzes the market for MEMS by devices and systems. The equipment and materials to make them are analyzed and forecast. Key Topics Covered: Chapter 1 The MEMS Market Infrastructure Chapter 2 Forecast Of The Key Applications And Markets 2.1 MEMS Device Market Forecast 2.2 MEMS System Market Forecast Chapter 3 Markets for Equipment and Materials Suppliers 3.1 Introduction 3.2 MEMS Equipment Markets 3.3 MEMS Material Markets Chapter 4 MEMS Foundries 4.1 Foundry Profiles and Strategies 4.2 Small-Mid-Sized Companies Chapter 5 Factors for Foundry Success Chapter 6 Critical MEMS Issues 6.1 3-D Interconnects and Packaging 6.2 Wafer Size 6.3 MEMS Testing 6.4 Opportunities For Fabless MEMS Companies Companies Featured: - Advanced Microsensors - Agiltron - Asia Pacific Microsystems - Beijing First MEMS - Bosch - China Resources Semiconductor - Colibrys - C2V - Dai-Nippon Printing - Dalso - Freescale - GLOBALFOUNDRIES - Honeywell MEMSplus - Infineon Technologies SensoNor As - Institute of Microelectronics - Innovative Micro Tech - Integrated Sensing Systems Inc. (ISSYS) - Micralayne - Micrel - Midwest MicroDevices, LLC - Nanostructures Inc - Norcada Inc. - Olympus - Omron - Proton Mikrotechnik - Semiconductor Manufacturing International Corporation - SEMEFAB - Silex Microsystems - Sony - ST Microelectronics - Taiwan Semiconductor Manufacturing Co Ltd (TSMC) - Texas Instruments - Touch Microsystems - Tronics Microsystems - X-Fab For more information visit http://www.researchandmarkets.com/research/fz...lobal_mems About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HON: 116.23 (+0.10), TXN: 69.56 (-0.14), TSM: 29.10 (+0.14), MCRL: 13.86 (-0.09)
Global Hardware Reconfigurable Devices Market 2015 - The Demand for Global Hardware Reconfigurable Devices is Growing at a Steady Pace Across the Globe
M2 - Wed Aug 12, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2kk32r/hardware) has announced the addition of the "Hardware Reconfigurable Devices Market - By Types of Device (On-Chip Memory, Auto-Sequencing Memory, Reconfigurable Computer and System Memory/Host Memory), By Process (Cycle Accurate Simulation, High-Performance Computing and Reconfigurable Computin" report to their offering. Hardware Reconfigurable Devices Market - By Types of Device (On-Chip Memory, Auto-Sequencing Memory, Reconfigurable Computer and System Memory/Host Memory) and By Process Type and By Geography This report categorizes the market into three different segments, namely: market by type of device, process, and geography. Based on the devices used, the market has been classified into On-chip memory, Auto-sequencing memory, Reconfigurable computer and System memory/Host memory. The processes include Cycle accurate simulation, High performance computing and Reconfigurable Computing. The demand for Global Hardware Reconfigurable Devices is growing at a steady pace across the globe. The Hardware Reconfigurable Devices market is growing due to the significant demand in the end-use sectors, especially the consumer class. Other factors affecting the growth of the market include technology innovation, efficiency and flexibility of hardware and availability of cheaper good quality materials. Key Topics Covered: 1. Global Hardware Reconfigurable Devices - Market Overview 2. Executive Summary 3. Global Hardware Reconfigurable Devices - Market Landscape 4. Global Hardware Reconfigurable Devices - Market Forces 5. Global Hardware Reconfigurable Devices Market - Strategic Analysis 6. Global Hardware Reconfigurable Devices - By Type of device 7. Global Hardware Reconfigurable Devices Market - By process type 8. Global Hardware Reconfigurable Devices Market -Geographic Analysis 9. Market Entropy 10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio) Companies Mentioned - Freescale Semiconductors - Infineon Technologies AG - Analog Devices - Texas Instruments - STMicroelectronics - Atmel Corporation - Broadcom Corporation - NVIDIA Corporation - Microchip Technologies - Micrel, Incorporated - Actel Corporation - Xilinx, Inc. - Altera Corporation - Lattice Semiconductor Corporation - SiliconBlue Technologies - Microsemi Corporation - Achronix Semiconductor Corp. For more information visit http://www.researchandmarkets.com/research/2kk32r/hardware
ATML: 8.14 (+0.02), LSCC: 6.20 (unch), XLNX: 54.47 (+0.23), BRCM: 54.67 (+0.17), TXN: 69.56 (-0.14), ALTR: 53.96 (+0.03), ADI: 63.09 (+0.03), MSCC: 40.01 (-0.38), MCRL: 13.86 (-0.09), NVDA: 62.24 (-0.91)
Microchip Technology And Micrel Announce The Completion Of The Acquisition Of Micrel By Microchip Technology
PR Newswire - Mon Aug 03, 3:48PM CDT
Microchip Technology Incorporated (NASDAQ: MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, and Micrel, Incorporated (NASDAQ: MCRL) today announced that Microchip has completed its previously announced acquisition of Micrel. Shareholders of Micrel overwhelmingly approved the merger with 98.95% of the Micrel shares that voted in favor of the merger. As a result of the completion of the transaction, trading in Micrel common stock on the NASDAQ Stock Market will cease today.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Microchip Technology Announces Record Non-GAAP Earnings Per Share For First Quarter Fiscal Year 2016
PR Newswire - Mon Aug 03, 3:45PM CDT
(NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today reported results for the three months ended June 30, 2015 as summarized in the following table:
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Micrel, Incorporated Announces Intent to Delist From NASDAQ
PR Newswire - Mon Jul 20, 3:15PM CDT
Micrel, Incorporated (NASDAQ: MCRL) ("Micrel"
today announced that it intends to delist Micrel's common stock from NASDAQ in connection with the pending acquisition of Micrel by Microchip Technology Incorporated ("Microchip" , by means of a first step merger of Mambo Acquisition Corp., a California corporation and wholly owned subsidiary of Microchip, with and into Micrel (the "Merger" , with Micrel surviving the Merger as a wholly owned subsidiary of Microchip (the "Interim Surviving Company" , and a second step merger of the Interim Surviving Company into Mambo Acquisition LLC, with Mambo Acquisition LLC surviving the second step merger as a wholly owned subsidiary of Microchip. The first step merger is expected to be completed on August 3, 2015, subject to adoption of the merger agreement by Micrel's shareholders and certain other conditions contained in the merger agreement.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Micrel Launches New 300mA, AEC-Q100-Compliant LDO Targeted At Growing Automotive Applications
PR Newswire - Mon Jul 20, 6:07AM CDT
Micrel Inc., (Nasdaq:MCRL), an industry leader in high-performance Linear and Power solutions, LAN and timing and communications solutions, today announced a new automotive AEC-Q100 qualified high-performance low-dropout voltage regulator (LDO) featuring an ultralow dropout of only 100mV at 300mA. The MAQ5300 comes in a tiny 2mm x 2mm DFN package and is ideal for space-constrained and high-reliability applications that are subjected to the harsh environments and temperatures often encountered in automotive and industrial applications. The MAQ5300 is currently available in volume, and pricing starts at $0.39 for 1K quantity. Samples can be ordered on line at: http://www.samplecomponents.com/scripts/sampl...dll?micrel.
MCRL: 13.86 (-0.09)
Micrel Launches A New Pin-Configurable, 19V, 5A DC/DC Converter Offered In A Tiny Package For Communication, Enterprise, Industrial Systems
PR Newswire - Wed Jul 08, 6:07AM CDT
Micrel, Inc. (Nasdaq: MCRL), an industry leader in high performance linear and power solutions, LAN and timing and communications solutions, today announced the availability of the MIC24046-H, a high efficiency (>90 percent peak), pin-configurable 5A synchronous buck converter in a tiny 3mm x 3mm QFN package. The device features pin selectable output voltage, switching frequency and current limit settings which improve design flexibility and eliminates multiple external components. The solution targets end equipment such as network switches/routers, servers, storage, base stations, FPGA and DSP power as well as factory automation and security cameras. The MIC24046-H is available in volume with pricing starting at $1.33 for 1,000 quantities. Samples can be ordered on line at: http://www.samplecomponents.com/scripts/sampl...dll?micrel.
MCRL: 13.86 (-0.09)
Microchip Receives Antitrust Clearance in Micrel Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 19, 10:10AM CDT
Microchip (MCHP) has received antitrust clearance in U.S. and Germany, in relation with its proposed acquisition of Micrel (MCRL).
BRCM: 54.67 (+0.17), MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09), AVGO: 173.18 (-3.91)
Microchip Technology Announces Receipt Of Antitrust Clearance In U.S. And Germany In Transaction To Acquire Micrel
PR Newswire - Thu Jun 18, 3:15PM CDT
(NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced, in connection with the previously announced definitive agreement under which Microchip will acquire Micrel, Incorporated (NASDAQ: MCRL), the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, had expired on June 15, 2015, and the Federal Cartel Office in Germany had cleared the transaction on June 17, 2015. There is no further antitrust clearance required for closure of the transaction. Completion of the merger remains subject to certain other closing conditions, including approval by Micrel shareholders of the merger. The special meeting of Micrel shareholders to approve the merger has not yet been set. Microchip continues to expect that the transaction will close in the third calendar quarter of 2015.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Previously Filed Form 10-K Available on Micrel's Website
Marketwired - Fri May 22, 3:05PM CDT
Micrel, Incorporated (NASDAQ: MCRL), a leading global manufacturer of IC solutions for the worldwide high performance linear and power, LAN and timing and communications markets, announced that its Form 10-K filed on February 24, 2015, and any amendments thereto, are available at: http://investor.micrel.com/financials.cfm. Shareholders of Micrel can also obtain hard copies, free of charge, upon request by calling: 408 474-1274 or by writing to Micrel, Incorporated, Attn: Corporate Secretary, 2180 Fortune Drive, San Jose, California 95131.
MCRL: 13.86 (-0.09)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Micrel, Inc.
BusinessWire - Fri May 22, 4:35AM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Micrel, Inc. ("Micrel" or "the Company" (Nasdaq: MCRL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Microchip Technology, Inc. ("Microchip" .
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Lawsuit for Investors in Micrel, Incorporated (Nasdaq:MCRL) Against Takeover Announced by Shareholders Foundation
GlobeNewswire - Wed May 20, 8:55AM CDT
The Shareholders Foundation, Inc. announces that an investor, who currently holds shares of Micrel, Incorporated (Nasdaq:MCRL), filed a lawsuit against the proposed acquisition of Micrel, Incorporated by Microchip Technology Incorporated for $14.00 per share.
MCRL: 13.86 (-0.09)
MICREL SHAREHOLDER NOTIFICATION: Faruqi & Faruqi, LLP Announces the Investigation of Micrel, Inc. Over the Proposed Sale of the Company to Microchip Technology Inc. - MCRL
PR Newswire - Tue May 19, 10:18AM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Micrel, Inc. ("Micrel" or the "Company" (Nasdaq: MCRL) for potential breaches of fiduciary duties in connection with the sale of the Company to Microchip Technology, Inc. (Nasdaq: MCHP) for approximately $839 million in a cash or stock transaction. The Company's stockholders will receive $14.00 for each share of Micrel common stock they own, and will elect to receive their compensation in either cash or stock. At least one analyst has set the price target for Micrel as high as $18.00 per share, $4.00 higher than the deal's price per share.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
LAWSUIT ALERT: Andrews & Springer LLC Announces That a Law Firm Has Filed a Class Action Lawsuit Against Micrel, Inc. - MCRL
GlobeNewswire - Tue May 19, 7:07AM CDT
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, announced today that a class action lawsuit has been filed by another law firm on behalf of stockholders of Micrel, Inc. (Nasdaq:MCRL) ("Micrel" or the "Company" seeking to challenge the Company's recently announced merger.
MCRL: 13.86 (-0.09)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Micrel Inc. of Commencement of an Investigation in Connection With the Fairness of the Sale of the Company to Microchip Technology Incorporated -- MCRL
PR Newswire - Mon May 18, 3:07PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Infusion Pumps Market 2015-2025 - 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide
M2 - Thu Dec 03, 7:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/h9gtdp/infusion_pumps) has announced the addition of the "Infusion Pumps Market, 2015-2025" report to their offering. The Infusion Pumps Market, 2015-2025 report provides a comprehensive study of the current state of infusion pumps market and the likely future evolution of these devices over the next decade. The study covers various types of infusion pumps that are used across several application areas. The current generation of these devices, being reliable and easy to use, have found wide acceptance in both homecare and hospital market. Infusion pumps are a class of drug delivery devices that have found wide adoption across different application areas. Their popularity can be attributed to their reliable, user friendly features and ergonomic design. The market has a wide array of different types of infusion pumps (volumetric, syringe, implantable, elastomeric, ambulatory and others); combined, they offer a large range of infusion volume, flow rate, occlusion alarm pressure range and many other technical parameters that can be adjusted according to the patient's requirements and care areas.These pumps have strengthened their position in a variety of application areas including oncology, diabetes, pain management, enteral feeding and general infusion. Several established firms as well as emerging players are currently competing in this market. Companies have regularly come up with technological advancements aimed at increasing the reliability and safety of these pumps. Examples of technological / design innovations include introduction of intuitive coloured touch screen, drug libraries, user friendly interface, compact design, improved accuracy, automated power saving mode and air-in-line detection.The introduction of smart infusion pumps has been an important step in the growth of this market. Despite the fact that the current market is significantly mature, a number of technological advancements from established and new players have sustained the growth momentum.Companies are continuously on the lookout for new avenues of growth in terms of novel features; this is expected to result in an even wider adoption going forward. Report Highlights: - During the course of our study, we identified over 300 infusion pumps that are currently being manufactured and commercialised by more than 60 companies worldwide. - The fragmented market is well distributed across different regions. Established companies such as (in alphabetical order) Baxter, B. Braun, Cane Medical Technology, Daiwha, Fresenius Kabi, GF Foures, Hospira, Medtronic, Micrel Medical Devices, Mindray, Smiths Medical, which have a wide portfolio of infusion pump devices are staring at growing competition from several mid-sized players and upcoming start-ups. - Examples of start-ups / smaller firms (in alphabetical order) include CareFusion, Cellnovo, CME Medical, Expanding Industry Limited, Flowonix, Summit Medical Products, Zyno Medical (complete list in Chapter 4). As has been observed in the case of other medical devices, the newer / smaller players will continue to foster more innovation and drive the market further. - The increasing number of partnerships among several players clearly indicates the growth and changes being witnessed in the market. These collaborations range from product / software development, distribution arrangements and acquisitions. - We expect the overall market to grow at an annualised growth rate of 3.8% during the period 2015-2025. Specific pockets of growth will come from wider adoption for oncology, diabetes and pain management applications. In terms of product types, ambulatory infusion pumps are likely to witness a relatively higher growth. - Advancements in device safety, software developments, accuracy rates and incorporation of additional user friendly features are likely to act as key enablers for future growth. The homecare market, specifically, is expected to grow its share in the future owing to the fact that it is cost effective and reduces the hospital expenses incurred by patients for various treatments. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Infusion Pumps For General Infusion 6. Infusion Pumps For Pain Management 7. Infusion Pumps For Oncology 8. Infusion Pumps For Insulin Administration 9. Case Studies 10. Market Forecast 11. Company Profiles 12. Conclusion 13. Appendix 1: Tabulated Data 14. Appendix 2: List Of Companies And Oragnisations Companies Mentioned - 3AF Group - AAMI Foundation - Abbott - Advanced Infusion - AKAS Medical - ALCOR Scientific - American Association of Critical-Care Nurses (AACN) - American Society of Regional Anaesthesia and Acute Pain Medicine (ASRA) - Amerinet - Angel Electronics - AngioDynamics - Animas - Arcomed - ASCOR - Asklepios Hospital Group - Atom Medical - B. Braun - Baxter - Becton Dickinson - Beijing KellyMed - Bigfoot Biomedical - Blue Box Medical - Cane Medical - CareFusion - Cellnovo - Centers for Disease Control and Prevention - Cerner - Changsha Jianyuan - CME Medical - CODAN ARGUS - Codman (J&J) - Committee for Medical Products for Human Use - CONNECT - Contec Medical - Covidien For more information visit http://www.researchandmarkets.com/research/h9...sion_pumps
MDT: 87.34 (+0.36), CFN: 59.91 (-0.06), MCRL: 13.86 (-0.09), CERN: 64.70 (-0.31)
Microchip Technology Announces Record Revenue For Second Quarter Fiscal Year 2016 And 100th Consecutive Quarter Of Profitability
PR Newswire - Wed Nov 04, 3:15PM CST
(NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today reported results for the three months ended September 30, 2015 as summarized in the following table:
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019
M2 - Wed Oct 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q92d5h/global_infusion) has announced the addition of the "Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019" report to their offering. Chronic pain is a worldwide burden that is estimated to have a burden of over 600 billion dollars in United States alone, whereas cancer and diabetes have an annual burden of US$ 243.0 billion and US$ 188.0 billion. This report provides an in-depth perspective on the revenue generated through demand from end-users such as Hospitals, HomeCare, Clinics and Infusion Centers or Infusion Pharmacies. It also provides another perspective of demand of infusion pumps market by applications such as Pain Management, Chemotherapy or Oncology, Infection Management (infusion of antimicrobial agents), Nutrition Management (Enteral and TPN), Insulin or Diabetes Management and Pediatric Infusion. Diabetes, cancer and chronic pain are long term illnesses that are increasing in incidence each year. In recent years the incidence and prevalence of diabetes has reached exponential levels with a global prevalence pegged by the WHO to be 9% worldwide among adults only. There is also a growing number of adolescent diabetes occurring worldwide. The rising population of diabetes coupled by increasing adoption of insulin pumps by Type II diabetics will propel the market for these devices in coming years. Increasing number of trauma patients are opting for implantable infusion pumps or IBT therapies. The combined rise of diabetes, cancer and chronic pain will push the market for infusion pumps significantly through the forecast period and even beyond it. With the advent of infusion pumps the medical community expected to reduce the number of errors, however even with all the medication administration errors, the single greatest source was human error. The most prominent disadvantage till recent times was that infusion pumps could not read the age, weight and other parameters of the patient from medical records in order to create filters and barriers for medication administration. The infusion pumps have to be programmed for use each time which have been causing massive errors where people have tragically died due to overdose of drugs. Close to 3 million people are estimated to rely on home infusions each year in United States alone and the trend is expected to be the same in Europe as well. Increasing demand for healthcare services and products to be reached in patient comfort zones will continue in coming years driving the growth of the market. The Medicare Home Infusion Site of Care Act of 2015 provides a pathway for reimbursement for the professional services, supplies and equipment associated with infusion therapy in the home under Medicare Part B. Commercial and research activities of over 40 players in the infusion devices market were analysed within this report. Infusion has been used in medicine since eons but has advanced very quickly in the last 20-30 odd years. There have been many strategies followed by companies to market their products and increase overall presence in various segments. Due to the integral working of pharmaceutical products and electronic devices together, the infusion pumps market lies at the overlap of the healthcare market which is broadly categorized into medical devices and pharmaceuticals. It is one of the largest drug delivery technologies today. The Global Infusion Pumps Market is highly fragmented. Key Topics Covered: Chapter 1 Preface Chapter 2 Pr?cis Chapter 3 Market Dynamics Chapter 4 Infusion Pumps & Accessories - Global Market Size Assessment, by Products, Forecast: 2015 - 2019 Chapter 5 Infusion Pumps - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019 Chapter 6 Infusion Pumps - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019 Chapter 7 Infusion Pumps & Accessories - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019 Chapter 8 Key Players Analysis: Infusion Pumps Market, 2014 (%) - 3AF Group - Akas Medical - Arcomed AG - Ascor SA - B Braun - Baxter - Caesarea Medical Electronics - CareFusion - CME Medical - Codan Argus - Codman & Shurtleff) - Diaken Medical Co Ltd - Flowonix - Fresnius Kabi - Halyard Medical - Hospira (Pfizer) - Insulet Corporation - Johnson & Johnson (Animas - KD Scientific - Medtronic Inc - Micrel Medical Devices - Mindray Medical - Moog Medical - Pancreum - Plenumtech - Roche - Schiller AG - Smiths Medical - Tandem - Tricumed - TSS Medical - Unilife - Zyno Medical For more information visit http://www.researchandmarkets.com/research/q9...l_infusion
JNJ: 119.22 (+0.14), PODD: 42.96 (+0.50), MDT: 87.34 (+0.36), MOG.A: 60.06 (+0.90), CFN: 59.91 (-0.06), MCRL: 13.86 (-0.09)
Microchip Technology Raises Guidance For Net Sales And EPS For Second Quarter Of Fiscal 2016
PR Newswire - Tue Sep 08, 6:00AM CDT
Microchip Technology Incorporated (NASDAQ: MCHP), a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today narrowed the range and increased the mid-point of its prior guidance for net sales and earnings per share for its fiscal second quarter of fiscal 2016 ending September 30, 2015. Microchip's core business is tracking towards our original guidance while Micrel sales for the partial quarter are ahead of our original guidance. Microchip previously provided guidance on August 3, 2015 for consolidated non-GAAP net sales to be between $532 million and $569 million with a mid- point of $550.5 million. Microchip now expects consolidated non-GAAP net sales to be between $545 million and $563 million with a mid-point of $554 million. Microchip now expects non-GAAP earnings per share to be between 60 and 66 cents per share. The original guidance for non-GAAP earning per share was between 58 and 66 cents per share.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
The Global MEMS Device, Equipment and Materials Markets: Forecasts and Strategies for Vendors and Foundries
M2 - Tue Sep 01, 11:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz9z2n/the_global_mems) has announced the addition of the "The Global MEMS Device, Equipment, and Materials Markets: Forecasts and Strategies for Vendors and Foundries" report to their offering. This vision of MEMS whereby microsensors, microactuators and microelectronics and other technologies, can be integrated onto a single microchip is expected to be one of the most important technological breakthroughs of the future. A significant portion of MEMS manufacturing technology has come from the IC industry. MEMS devices can be made using silicon wafers and the manufacturing process can incorporates semiconductor manufacturing processes such as sputtering, deposition, etching and lithography. This report analyzes the market for MEMS by devices and systems. The equipment and materials to make them are analyzed and forecast. Key Topics Covered: Chapter 1 The MEMS Market Infrastructure Chapter 2 Forecast Of The Key Applications And Markets 2.1 MEMS Device Market Forecast 2.2 MEMS System Market Forecast Chapter 3 Markets for Equipment and Materials Suppliers 3.1 Introduction 3.2 MEMS Equipment Markets 3.3 MEMS Material Markets Chapter 4 MEMS Foundries 4.1 Foundry Profiles and Strategies 4.2 Small-Mid-Sized Companies Chapter 5 Factors for Foundry Success Chapter 6 Critical MEMS Issues 6.1 3-D Interconnects and Packaging 6.2 Wafer Size 6.3 MEMS Testing 6.4 Opportunities For Fabless MEMS Companies Companies Featured: - Advanced Microsensors - Agiltron - Asia Pacific Microsystems - Beijing First MEMS - Bosch - China Resources Semiconductor - Colibrys - C2V - Dai-Nippon Printing - Dalso - Freescale - GLOBALFOUNDRIES - Honeywell MEMSplus - Infineon Technologies SensoNor As - Institute of Microelectronics - Innovative Micro Tech - Integrated Sensing Systems Inc. (ISSYS) - Micralayne - Micrel - Midwest MicroDevices, LLC - Nanostructures Inc - Norcada Inc. - Olympus - Omron - Proton Mikrotechnik - Semiconductor Manufacturing International Corporation - SEMEFAB - Silex Microsystems - Sony - ST Microelectronics - Taiwan Semiconductor Manufacturing Co Ltd (TSMC) - Texas Instruments - Touch Microsystems - Tronics Microsystems - X-Fab For more information visit http://www.researchandmarkets.com/research/fz...lobal_mems About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HON: 116.23 (+0.10), TXN: 69.56 (-0.14), TSM: 29.10 (+0.14), MCRL: 13.86 (-0.09)
Global Hardware Reconfigurable Devices Market 2015 - The Demand for Global Hardware Reconfigurable Devices is Growing at a Steady Pace Across the Globe
M2 - Wed Aug 12, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2kk32r/hardware) has announced the addition of the "Hardware Reconfigurable Devices Market - By Types of Device (On-Chip Memory, Auto-Sequencing Memory, Reconfigurable Computer and System Memory/Host Memory), By Process (Cycle Accurate Simulation, High-Performance Computing and Reconfigurable Computin" report to their offering. Hardware Reconfigurable Devices Market - By Types of Device (On-Chip Memory, Auto-Sequencing Memory, Reconfigurable Computer and System Memory/Host Memory) and By Process Type and By Geography This report categorizes the market into three different segments, namely: market by type of device, process, and geography. Based on the devices used, the market has been classified into On-chip memory, Auto-sequencing memory, Reconfigurable computer and System memory/Host memory. The processes include Cycle accurate simulation, High performance computing and Reconfigurable Computing. The demand for Global Hardware Reconfigurable Devices is growing at a steady pace across the globe. The Hardware Reconfigurable Devices market is growing due to the significant demand in the end-use sectors, especially the consumer class. Other factors affecting the growth of the market include technology innovation, efficiency and flexibility of hardware and availability of cheaper good quality materials. Key Topics Covered: 1. Global Hardware Reconfigurable Devices - Market Overview 2. Executive Summary 3. Global Hardware Reconfigurable Devices - Market Landscape 4. Global Hardware Reconfigurable Devices - Market Forces 5. Global Hardware Reconfigurable Devices Market - Strategic Analysis 6. Global Hardware Reconfigurable Devices - By Type of device 7. Global Hardware Reconfigurable Devices Market - By process type 8. Global Hardware Reconfigurable Devices Market -Geographic Analysis 9. Market Entropy 10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio) Companies Mentioned - Freescale Semiconductors - Infineon Technologies AG - Analog Devices - Texas Instruments - STMicroelectronics - Atmel Corporation - Broadcom Corporation - NVIDIA Corporation - Microchip Technologies - Micrel, Incorporated - Actel Corporation - Xilinx, Inc. - Altera Corporation - Lattice Semiconductor Corporation - SiliconBlue Technologies - Microsemi Corporation - Achronix Semiconductor Corp. For more information visit http://www.researchandmarkets.com/research/2kk32r/hardware
ATML: 8.14 (+0.02), LSCC: 6.20 (unch), XLNX: 54.47 (+0.23), BRCM: 54.67 (+0.17), TXN: 69.56 (-0.14), ALTR: 53.96 (+0.03), ADI: 63.09 (+0.03), MSCC: 40.01 (-0.38), MCRL: 13.86 (-0.09), NVDA: 62.24 (-0.91)
Microchip Technology And Micrel Announce The Completion Of The Acquisition Of Micrel By Microchip Technology
PR Newswire - Mon Aug 03, 3:48PM CDT
Microchip Technology Incorporated (NASDAQ: MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, and Micrel, Incorporated (NASDAQ: MCRL) today announced that Microchip has completed its previously announced acquisition of Micrel. Shareholders of Micrel overwhelmingly approved the merger with 98.95% of the Micrel shares that voted in favor of the merger. As a result of the completion of the transaction, trading in Micrel common stock on the NASDAQ Stock Market will cease today.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Microchip Technology Announces Record Non-GAAP Earnings Per Share For First Quarter Fiscal Year 2016
PR Newswire - Mon Aug 03, 3:45PM CDT
(NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today reported results for the three months ended June 30, 2015 as summarized in the following table:
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Micrel, Incorporated Announces Intent to Delist From NASDAQ
PR Newswire - Mon Jul 20, 3:15PM CDT
Micrel, Incorporated (NASDAQ: MCRL) ("Micrel"
today announced that it intends to delist Micrel's common stock from NASDAQ in connection with the pending acquisition of Micrel by Microchip Technology Incorporated ("Microchip" , by means of a first step merger of Mambo Acquisition Corp., a California corporation and wholly owned subsidiary of Microchip, with and into Micrel (the "Merger" , with Micrel surviving the Merger as a wholly owned subsidiary of Microchip (the "Interim Surviving Company" , and a second step merger of the Interim Surviving Company into Mambo Acquisition LLC, with Mambo Acquisition LLC surviving the second step merger as a wholly owned subsidiary of Microchip. The first step merger is expected to be completed on August 3, 2015, subject to adoption of the merger agreement by Micrel's shareholders and certain other conditions contained in the merger agreement. MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Micrel Launches New 300mA, AEC-Q100-Compliant LDO Targeted At Growing Automotive Applications
PR Newswire - Mon Jul 20, 6:07AM CDT
Micrel Inc., (Nasdaq:MCRL), an industry leader in high-performance Linear and Power solutions, LAN and timing and communications solutions, today announced a new automotive AEC-Q100 qualified high-performance low-dropout voltage regulator (LDO) featuring an ultralow dropout of only 100mV at 300mA. The MAQ5300 comes in a tiny 2mm x 2mm DFN package and is ideal for space-constrained and high-reliability applications that are subjected to the harsh environments and temperatures often encountered in automotive and industrial applications. The MAQ5300 is currently available in volume, and pricing starts at $0.39 for 1K quantity. Samples can be ordered on line at: http://www.samplecomponents.com/scripts/sampl...dll?micrel.
MCRL: 13.86 (-0.09)
Micrel Launches A New Pin-Configurable, 19V, 5A DC/DC Converter Offered In A Tiny Package For Communication, Enterprise, Industrial Systems
PR Newswire - Wed Jul 08, 6:07AM CDT
Micrel, Inc. (Nasdaq: MCRL), an industry leader in high performance linear and power solutions, LAN and timing and communications solutions, today announced the availability of the MIC24046-H, a high efficiency (>90 percent peak), pin-configurable 5A synchronous buck converter in a tiny 3mm x 3mm QFN package. The device features pin selectable output voltage, switching frequency and current limit settings which improve design flexibility and eliminates multiple external components. The solution targets end equipment such as network switches/routers, servers, storage, base stations, FPGA and DSP power as well as factory automation and security cameras. The MIC24046-H is available in volume with pricing starting at $1.33 for 1,000 quantities. Samples can be ordered on line at: http://www.samplecomponents.com/scripts/sampl...dll?micrel.
MCRL: 13.86 (-0.09)
Microchip Receives Antitrust Clearance in Micrel Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 19, 10:10AM CDT
Microchip (MCHP) has received antitrust clearance in U.S. and Germany, in relation with its proposed acquisition of Micrel (MCRL).
BRCM: 54.67 (+0.17), MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09), AVGO: 173.18 (-3.91)
Microchip Technology Announces Receipt Of Antitrust Clearance In U.S. And Germany In Transaction To Acquire Micrel
PR Newswire - Thu Jun 18, 3:15PM CDT
(NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced, in connection with the previously announced definitive agreement under which Microchip will acquire Micrel, Incorporated (NASDAQ: MCRL), the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, had expired on June 15, 2015, and the Federal Cartel Office in Germany had cleared the transaction on June 17, 2015. There is no further antitrust clearance required for closure of the transaction. Completion of the merger remains subject to certain other closing conditions, including approval by Micrel shareholders of the merger. The special meeting of Micrel shareholders to approve the merger has not yet been set. Microchip continues to expect that the transaction will close in the third calendar quarter of 2015.
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Previously Filed Form 10-K Available on Micrel's Website
Marketwired - Fri May 22, 3:05PM CDT
Micrel, Incorporated (NASDAQ: MCRL), a leading global manufacturer of IC solutions for the worldwide high performance linear and power, LAN and timing and communications markets, announced that its Form 10-K filed on February 24, 2015, and any amendments thereto, are available at: http://investor.micrel.com/financials.cfm. Shareholders of Micrel can also obtain hard copies, free of charge, upon request by calling: 408 474-1274 or by writing to Micrel, Incorporated, Attn: Corporate Secretary, 2180 Fortune Drive, San Jose, California 95131.
MCRL: 13.86 (-0.09)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Micrel, Inc.
BusinessWire - Fri May 22, 4:35AM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Micrel, Inc. ("Micrel" or "the Company"
(Nasdaq: MCRL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Microchip Technology, Inc. ("Microchip" . MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
Lawsuit for Investors in Micrel, Incorporated (Nasdaq:MCRL) Against Takeover Announced by Shareholders Foundation
GlobeNewswire - Wed May 20, 8:55AM CDT
The Shareholders Foundation, Inc. announces that an investor, who currently holds shares of Micrel, Incorporated (Nasdaq:MCRL), filed a lawsuit against the proposed acquisition of Micrel, Incorporated by Microchip Technology Incorporated for $14.00 per share.
MCRL: 13.86 (-0.09)
MICREL SHAREHOLDER NOTIFICATION: Faruqi & Faruqi, LLP Announces the Investigation of Micrel, Inc. Over the Proposed Sale of the Company to Microchip Technology Inc. - MCRL
PR Newswire - Tue May 19, 10:18AM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Micrel, Inc. ("Micrel" or the "Company"
(Nasdaq: MCRL) for potential breaches of fiduciary duties in connection with the sale of the Company to Microchip Technology, Inc. (Nasdaq: MCHP) for approximately $839 million in a cash or stock transaction. The Company's stockholders will receive $14.00 for each share of Micrel common stock they own, and will elect to receive their compensation in either cash or stock. At least one analyst has set the price target for Micrel as high as $18.00 per share, $4.00 higher than the deal's price per share. MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
LAWSUIT ALERT: Andrews & Springer LLC Announces That a Law Firm Has Filed a Class Action Lawsuit Against Micrel, Inc. - MCRL
GlobeNewswire - Tue May 19, 7:07AM CDT
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, announced today that a class action lawsuit has been filed by another law firm on behalf of stockholders of Micrel, Inc. (Nasdaq:MCRL) ("Micrel" or the "Company"
seeking to challenge the Company's recently announced merger. MCRL: 13.86 (-0.09)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Micrel Inc. of Commencement of an Investigation in Connection With the Fairness of the Sale of the Company to Microchip Technology Incorporated -- MCRL
PR Newswire - Mon May 18, 3:07PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
MCHP: 62.44 (-0.36), MCRL: 13.86 (-0.09)
(0)
(0)Scroll down for more posts ▼